Obesity. Other glycogen storage disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Estimation of body mass index = 25 and complete consent to participate in the study and complete the treatment process
Exclusion criteria
Exclusion criteria: patients with known diseases such as cardiovascular diabetes mellitus If you have epilepsy Tumors cancer mental disorders contagious skin infections light-sensitization not be pregnant or breastfeeding They were excluded if they took any of the drugs that were effective on weight within one month before the study Kidney Disorders Endocrine Disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body mass. Timepoint: One time before patients were assigned to groups and one time at the end time. Method of measurement: Laboratory testing and ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass and body size changes due to fat loss. Timepoint: One time before patients were assigned to groups and one time at the end time. Method of measurement: Laboratory testing and sonography and sf36 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences